NSE › Healthcare

3B Blackbio Dx Limited (3BBLACKBIO)

NSE · Healthcare · Biotechnology

₹1,284.20-1.90%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

₹33 cr

Revenue YoY

+50.6%

Net profit

₹10 cr

Profit YoY

-24.3%

Net margin

28.5%

Key statistics

Market cap

₹1,112 cr

P/E

19.7

Forward P/E

0.0

P/B

3.43

Book value

₹388.37

EPS (TTM)

₹65.81

52-week high

₹1,740.00

52-week low

₹1,095.60

50-day MA

₹1,431.16

200-day MA

₹1,420.20

Beta

0.38

Shareholding

Promoters

64.11%

Institutions

1.95%

Corporate actions

Action	Detail	Date
Dividend	₹5 / share ex-date Sep 22, 2026	2026-09-22

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for 3B Blackbio Dx Limited — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Laurus Labs Limited Lenskart Solutions Ltd Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Dr. Reddy's Laboratories Limited Cipla Limited Mankind Pharma Ltd Aurobindo Pharma Limited Lupin Limited

Data updated 2026-11-07.